Vioquest Pharmaceutl (VOQP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,420 | 650 | 910 | 1,790 | 2,410 |
| Receivables | 100 | 50 | 100 | 60 | 30 |
| Inventories | 140 | 70 | 80 | 30 | 30 |
| Other current assets | 60 | 60 | 70 | 20 | 10 |
| TOTAL | $6,720 | $830 | $1,160 | $1,900 | $2,480 |
| Non-Current Assets | |||||
| Investments And Advances | 20 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 430 | 490 | 390 | 340 | 320 |
| TOTAL | $450 | $490 | $390 | $340 | $320 |
| Total Assets | $7,480 | $1,580 | $1,790 | $2,440 | $2,870 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 270 | 70 | 210 | 210 |
| Accrued Expenses | 190 | 220 | 80 | 180 | 80 |
| Other current liabilities | 220 | 220 | 230 | 150 | 130 |
| TOTAL | $580 | $720 | $390 | $540 | $430 |
| Non-Current Liabilities | |||||
| TOTAL | $40 | $40 | $70 | $100 | $130 |
| Total Liabilities | $620 | $760 | $460 | $640 | $570 |
| Shareholders' Equity | |||||
| Common Shares | 170 | 130 | 130 | 130 | 130 |
| Retained earnings | -4,150 | -3,410 | -2,840 | -2,290 | -1,730 |
| Other shareholders' equity | -670 | -760 | -890 | -900 | -320 |
| TOTAL | $6,850 | $820 | $1,320 | $1,790 | $2,300 |
| Total Liabilities And Equity | $7,470 | $1,580 | $1,780 | $2,430 | $2,870 |